44.09
1.08%
0.47
プレマーケット:
44.10
0.010
+0.02%
前日終値:
$43.62
開ける:
$43.71
24時間の取引高:
599.68K
Relative Volume:
1.75
時価総額:
$2.13B
収益:
$712.89M
当期純損益:
$166.52M
株価収益率:
22.61
EPS:
1.95
ネットキャッシュフロー:
$178.13M
1週間 パフォーマンス:
-3.06%
1か月 パフォーマンス:
-13.28%
6か月 パフォーマンス:
+2.37%
1年 パフォーマンス:
-22.09%
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
名前
Amphastar Pharmaceuticals Inc
セクター
電話
909-980-9484
住所
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
AMPH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
AMPH | 44.09 | 2.13B | 712.89M | 166.52M | 178.13M | 1.95 |
ZTS | 175.67 | 78.47B | 9.15B | 2.43B | 2.31B | 4.92 |
HLN | 9.48 | 42.84B | 14.26B | 1.55B | 0 | 0.3327 |
TAK | 13.29 | 42.13B | 30.27B | 1.93B | 3.45B | 0.444 |
TEVA | 17.03 | 19.19B | 16.77B | -959.00M | 1.37B | -2.00 |
VTRS | 13.13 | 15.67B | 15.24B | -646.50M | 1.88B | 1.53 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-11-17 | 開始されました | BofA Securities | Neutral |
2023-07-25 | 再開されました | Jefferies | Buy |
2022-10-21 | 再開されました | Jefferies | Buy |
2022-07-29 | 開始されました | CapitalOne | Overweight |
2022-01-07 | アップグレード | Piper Sandler | Neutral → Overweight |
2021-01-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2020-10-05 | アップグレード | Northland Capital | Market Perform → Outperform |
2020-05-01 | 開始されました | Northland Capital | Outperform |
2019-03-13 | ダウングレード | Needham | Buy → Hold |
2019-03-13 | ダウングレード | Piper Jaffray | Overweight → Neutral |
2018-08-10 | 繰り返されました | Needham | Buy |
2018-03-13 | 繰り返されました | Needham | Buy |
2017-12-01 | 繰り返されました | Needham | Buy |
2017-11-09 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2017-09-27 | 繰り返されました | Needham | Buy |
2017-03-14 | ダウングレード | Raymond James | Strong Buy → Outperform |
2016-08-09 | 繰り返されました | Needham | Buy |
2016-05-10 | 繰り返されました | Needham | Buy |
2016-02-19 | 開始されました | Wells Fargo | Outperform |
2015-06-19 | 繰り返されました | Needham | Buy |
2015-06-03 | 開始されました | Raymond James | Strong Buy |
2014-07-21 | 開始されました | Needham | Buy |
すべてを表示
Amphastar Pharmaceuticals Inc (AMPH) 最新ニュース
Injectables Contraceptives Market with Promising Opportunity - openPR
Principal Financial Group Inc. Has $9.80 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Principal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
16,169 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Los Angeles Capital Management LLC - MarketBeat
Amphastar Pharmaceuticals executive sells $336,929 in stock - Investing.com
Amphastar Pharmaceuticals director Richard Prins sells $243,985 in stock - Investing.com India
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference - AccessWire
Amphastar Pharmaceuticals to Present at Jefferies London Healthcare Conference | AMPH Stock News - StockTitan
Amphastar Pharmaceuticals Inc (AMPH) Stock Price Down 3.5% on No - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by US Bancorp DE - Defense World
FDA Approves Amphastar's New Epinephrine Drug, Boosting Market Growth - openPR
Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings - MSN
Amphastar Pharmaceuticals Reports Strong Q3 2024 Results - TipRanks
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by New York State Teachers Retirement System - Defense World
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 5,214 Shares of Stock - MarketBeat
William J. Peters Sells 7,426 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock - MarketBeat
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St
Amphastar Pharmaceuticals executive sells $271,388 in stock By Investing.com - Investing.com Nigeria
Amphastar Pharmaceuticals executive sells $271,388 in stock - Investing.com
Amphastar CFO William J. Peters sells shares for $386,523 - Investing.com
Amphastar CFO William J. Peters sells shares for $386,523 By Investing.com - Investing.com Canada
Amphastar Pharmaceuticals Inc (AMPH) Shares Up 3.62% on Nov 8 - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call Transcript - Insider Monkey
Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap DownTime to Sell? - MarketBeat
Amphastar: Q3 Earnings Snapshot - Houston Chronicle
Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates - Yahoo Finance
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024 - AccessWire
Amphastar Q3 Revenue Hits $191.2M; BAQSIMI Sales Shine as Board Boosts Buyback Program | AMPH Stock News - StockTitan
Hyaluronidase Market Set for Rapid Expansion (2024-2031): - openPR
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Pre - GuruFocus.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World
Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Rating Lowered to “Hold” at StockNews.com - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Downgraded to Hold Rating by StockNews.com - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Raymond James & Associates - Defense World
Allspring Global Investments Holdings LLC Trims Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
International Assets Investment Management LLC Buys Shares of 22,809 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Trend Tracker for (AMPH) - Stock Traders Daily
Amphastar Pharmaceuticals (AMPH) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024 - AccessWire
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Boston Trust Walden Corp Purchases Shares of 539,639 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now? - Yahoo Finance
Amphastar: Objectively Undervalued But For Good Reason (Rating Downgrade) (AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Moody Aldrich Partners LLC - MarketBeat
Possible Bearish Signals With Amphastar Pharmaceuticals Insiders Disposing Stock - Simply Wall St
nVerses Capital LLC Buys 400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report? - MSN
Amphastar Pharmaceuticals Inc (AMPH) 財務データ
収益
当期純利益
現金流量
EPS
Amphastar Pharmaceuticals Inc (AMPH) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Nov 12 '24 |
Sale |
48.88 |
6,893 |
336,930 |
118,388 |
PRINS RICHARD K | Director |
Nov 12 '24 |
Option Exercise |
16.69 |
2,500 |
41,725 |
36,471 |
PRINS RICHARD K | Director |
Nov 12 '24 |
Sale |
48.80 |
5,000 |
243,986 |
31,471 |
大文字化:
|
ボリューム (24 時間):